BioTime Inc. is engaged in the business of developing blood plasma volume expanders and related products and stem cell related products and technology for diagnostic therapeutic and research use.


Updates from The Motley Fool

Latest updates on BioTime from Fool.com.
3 Reasons Behind Geron's Rebound

Let’s take a look at three reasons Geron bounced back more than 200% in 2013, and how its industr...

The Worst of 2012: BioTime

Continuing our countdown of the very worst healthcare stocks of 2012, BioTime comes in at No. 20.

The Bearish Case for BioTime

A light R&D budget, a technology that may not be commercially viable, and a stock prone to promot...



Stock Performance

View Interactive BTX Charts
Sponsored by

Key Data Points

Primary metrics and data points about BioTime.
Current Price: $2.92
Prev Close: $2.94
Open: $2.94
Bid: $2.87
Ask: $2.99
Day's Range: $2.88 - $2.98
52wk Range: $2.67 - $4.00
Volume: 283,003
Avg Vol 415,844
Market Cap: $324M
P/E (ttm): -16.33
EPS (ttm): ($0.18)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about BioTime.
CAPS Rating 3 out of 5
 
66 Outperform
36 Underperform
CAPS All Stars
 
5 Outperform
12 Underperform

How do you think BioTime will perform against the market?



You pick for BioTime is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Michael D. West, CEO

43% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for BioTime.

BioTime Inc. is engaged in the business of developing blood plasma volume expanders and related products and stem cell related products and technology for diagnostic therapeutic and research use.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers